Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(CSE:
GDBY
)
N/A
UNCHANGED
Last Price
Updated: 9:53 AM EDT, Aug 17, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GDBY
< Previous
1
2
Next >
Goodbody Health Progress Update: Phlebotomy Services
January 31, 2023
Via
ACCESSWIRE
Goodbody Health Partners with Datar to Offer Innovative Cancer Screening
January 26, 2023
Via
ACCESSWIRE
Board Updates
December 29, 2022
Via
ACCESSWIRE
Goodbody Health Announces Cash Injection for Growth Through Divestment of Polish CBD Operations
December 16, 2022
Via
ACCESSWIRE
Board Update
December 01, 2022
Via
ACCESSWIRE
Goodbody Health Limited Publishes Financial Results Q3 2022
November 10, 2022
Via
ACCESSWIRE
Goodbody Health Limited (Previously: Goodbody Health Inc.) Director Transfer of Ordinary Shares
August 30, 2022
Via
ACCESSWIRE
Goodbody Health Inc. (Renamed: Goodbody Health Limited) Provides Shareholders Update on Completion of Continuation
August 23, 2022
Via
ACCESSWIRE
Goodbody Health Inc Publishes Half Year Financial Results Q2 2022
August 19, 2022
Via
ACCESSWIRE
Goodbody Health Inc. Provides Annual General and Special Meeting of Shareholders Update
August 10, 2022
Via
ACCESSWIRE
Goodbody Health Announces Annual General and Special Meeting of Shareholders
July 14, 2022
VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), announces that further to its news release dated June 10, 2022, the Company has...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular Diseases
June 20, 2022
VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Granted Care Quality Commission Registration
June 16, 2022
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration...
From
Goodbody Health Inc.
Via
AccessWire
AGM, Plan to De-List from the CSE, Redomicile to Guernsey, And Appointment of Peterhouse as Corporate Adviser
June 10, 2022
Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Announces the Launch of Its Core Health Diagnostic Check
May 26, 2022
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Inc. Publishes Highest Quarterly Profit to Date in Q1 2022
May 25, 2022
VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and...
From
Goodbody Health Inc.
Via
AccessWire
Exposures
COVID-19
Goodbody Health Inc. Publishes 2021 Audited Financial Statements
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence
April 11, 2022
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that its subsidiary, PhytoVista Laboratories, has...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Products Included on FSA Novel Foods Register
March 31, 2022
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, following the UK Food Standard Agencies...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Confirms Strong 2021 Revenue Continuing into 2022
March 10, 2022
VANCOUVER, BC / ACCESSWIRE / March 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, the unaudited revenue figures for the year...
From
Goodbody Health Inc.
Via
AccessWire
Exposures
COVID-19
Goodbody Health Announces Blood Testing Technology Roll Out
March 08, 2022
VANCOUVER, BC / ACCESSWIRE / March 8, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) (Goodbody Health" or the "Company") is pleased to announce that, following a pilot project using new technology...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Announces Normal Course Issuer Bid and Restricted Share Unit Plan
March 04, 2022
VANCOUVER, BC / ACCESSWIRE / March 4, 2022 / Goodbody Health Inc. (CSE:GDBY), (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce: (i) its intention to initiate a normal course...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Announces Moves up to OTCQB
February 22, 2022
VANCOUVER, BC / ACCESSWIRE / February 22, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it has moved up a tier from the over the...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Announces Opening of First Clinic in Canada
February 18, 2022
VANCOUVER, BC / ACCESSWIRE / February 18, 2022 / Goodbody Health Inc. (CSE:GDBY) (Goodbody Health" or the "Company") is pleased to announce that following its successful rollout of Goodbody testing...
From
Goodbody Health Inc.
Via
AccessWire
Exposures
COVID-19
Introduction of Innovative PCR-Based Detection Methods Surges Fueled by Pandemic and Other Diseases
February 18, 2022
Palm Beach, FL – February 18, 2022 – FinancialNewsMedia.com News Commentary – PCR testing and the COVID-19 diagnostic testing market has, unexpectantly, been growing at a substantial rate the past few...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
GOODBODY HEALTH ANNOUNCES FIRST CLINIC IN CANADA
February 18, 2022
Vancouver, BC – February 18, 2022 – Goodbody Health Inc. (CSE: GDBY) (Goodbody Health” or the “Company”) is pleased to announce that following its successful rollout of Goodbody testing clinics in the...
Via
FinancialNewsMedia
Exposures
COVID-19
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
February 16, 2022
Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years....
Via
FinancialNewsMedia
Exposures
COVID-19
GOODBODY HEALTH ANNOUNCES BLOOD TESTING TRIAL SUCCESS
February 16, 2022
Vancouver, BC – February 16, 2022 – Goodbody Health Inc. (OTCPK: GDBYF) (CSE: GDBY) (Goodbody Health” or the “Company”) is pleased to announce the rollout of its plan to introduce blood testing through...
Via
FinancialNewsMedia
Goodbody Health Announces Blood Testing Trial Success
February 16, 2022
VANCOUVER, BC / ACCESSWIRE / February 16, 2022 / Goodbody Health Inc. (CSE:GDBY) (Goodbody Health" or the "Company") is pleased to announce the rollout of its plan to introduce blood testing through...
From
Goodbody Health Inc.
Via
AccessWire
Goodbody Health Announces Extension of Scope of ISO 17025
February 07, 2022
VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased to announce its subsidiary Phytovista Laboratories has achieved another...
From
Goodbody Health Inc.
Via
AccessWire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.